REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q3 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,256,956 | -17.4% | 562,391 | +0.3% | 0.06% | -15.4% |
| Q2 2023 | $11,212,351 | -6.2% | 560,898 | -11.3% | 0.06% | -11.0% |
| Q1 2023 | $11,958,268 | +1844.0% | 632,378 | +2231.5% | 0.07% | +1725.0% |
| Q4 2022 | $615,150 | +119.7% | 27,123 | +156.1% | 0.00% | +100.0% |
| Q3 2022 | $280,000 | -92.8% | 10,592 | -93.3% | 0.00% | -93.3% |
| Q2 2022 | $3,909,000 | -32.7% | 158,252 | -9.5% | 0.03% | -23.1% |
| Q1 2022 | $5,805,000 | -16.8% | 174,912 | -2.6% | 0.04% | -17.0% |
| Q2 2021 | $6,974,000 | +6.8% | 179,521 | -6.2% | 0.05% | -6.0% |
| Q1 2021 | $6,531,000 | +432.3% | 191,464 | +607.9% | 0.05% | +354.5% |
| Q4 2020 | $1,227,000 | +56.1% | 27,048 | -5.3% | 0.01% | +37.5% |
| Q3 2020 | $786,000 | -36.9% | 28,566 | -15.6% | 0.01% | -38.5% |
| Q2 2020 | $1,246,000 | – | 33,827 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |